Preclinical evaluation of the antineoplastic action of 5-aza-2'-deoxycytidine and different histone deacetylase inhibitors on human Ewing's sarcoma cells

Eitemau Tebyg

• Inhibition of DNA and Histone Methylation by 5-Aza-2′-Deoxycytidine (Decitabine) and 3-Deazaneplanocin-A on Antineoplastic Action and Gene Expression in Myeloid Leukemic Cells
  gan: Momparler, Richard L., et al.
  Cyhoeddwyd: (2017)
• Importance of dose-schedule of 5-aza-2'-deoxycytidine for epigenetic therapy of cancer
  gan: Lemaire, Maryse, et al.
  Cyhoeddwyd: (2008)
• Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation
  gan: Momparler, Richard L, et al.
  Cyhoeddwyd: (2014)
• Histone Deacetylase Inhibitor: Antineoplastic Agent and Radiation Modulator
  gan: Konsoula, Zacharoula, et al.
  Cyhoeddwyd: (2011)
• Sequential treatment with 5‐aza‐2′‐deoxycytidine and deacetylase inhibitors reactivates HIV‐1
  gan: Bouchat, Sophie, et al.
  Cyhoeddwyd: (2015)